Determinants of variability of five programmed death ligand-1 immunohistochemistry assays in non-small cell lung cancer samples

Programmed death ligand-1 (PD-L1) expression as determined by immunohistochemistry (IHC) is potentially predictive of clinical outcome. The aim of this study was to assess the concordance of reported PD-L1 IHC assays and investigate factors influencing variability. Consecutive sections from 20 non-s...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Oncotarget
Asıl Yazarlar: Soo, Ross A., Yun Lim, Joey Sze, Asuncion, Bernadette Reyna, Fazreen, Zul, Herrera, Maria Cynthia, Mohd Omar, Mohd Feroz, Diem Phuong, Nguyen Hoang, Seet, Ju Ee, Amanuel, Benhur, Iacopetta, Barry, Byrne, David, Hendry, Shona, Fox, Stephen, Soong, Richie
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Impact Journals LLC 2018
Konular:
Research Paper
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5805519/
https://ncbi.nlm.nih.gov/pubmed/29467933
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.23827
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller